Breaking News
March 22, 2018 - FDA Approves Ilumya (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
March 22, 2018 - Beer Raises Heart Rate; KardiaBand Hyperkalemia Test; CHD Clinics
March 22, 2018 - A retinal implant that is more effective against blindness
March 22, 2018 - New system based on artificial intelligence provides reliable detection of breast cancer
March 22, 2018 - Research offers new understanding about cause of Parkinson’s disease
March 22, 2018 - HORIBA’s Microsemi CRP analyzer improves quality of care in emergency pediatric units, study shows
March 22, 2018 - Range of Vaginal Dryness Products Can Help Postmenopausal Women: Study
March 22, 2018 - Higher Dose Tx Deemed Safe in Pulmonary TB
March 22, 2018 - Discovery of new ALS gene points to cytoskeleton as potential target for drug development
March 22, 2018 - Diet soda associated with higher odds of diabetic retinopathy
March 22, 2018 - LSD reduces ‘sense of self’
March 22, 2018 - Vitamin D deficiency linked to metabolic syndrome in postmenopausal women
March 22, 2018 - Changes in the intestines may be responsible for reversal of diabetes after bariatric surgery
March 22, 2018 - iPads and Cancer; Clot Retrieval and Stroke: It’s PodMed Double T!
March 22, 2018 - Premature births linked to changes in mother’s bacteria
March 22, 2018 - Brain SPECT scans predict treatment outcomes in patients with depression
March 21, 2018 - Researchers succeed in integrating artificial organelles into cells of living organism
March 21, 2018 - Researchers discover ‘missing mutation’ in severe infant epilepsy
March 21, 2018 - Researchers develop statistics-based computational scheme to zoom in on brain function
March 21, 2018 - Verge joins Genomics England’s Discovery Forum industry partnership
March 21, 2018 - Trovagene Announces First Patient Successfully Completes Cycle 1 of Treatment with PCM-075 in Combination with Low Dose Cytarabine (LDAC) in AML Trial
March 21, 2018 - Congenital Cardiac Cath Tx Often Strays from Guidelines
March 21, 2018 - Marked increase in cardiovascular risk factors in women after preeclampsia
March 21, 2018 - New app may help predict, track manic and depressive episodes in bipolar patients
March 21, 2018 - Discovery of genes could lead to development of novel therapies for EBV-related cancers
March 21, 2018 - High-fat, high-cholesterol diet depletes ranks of artery-protecting immune cells
March 21, 2018 - Research misconduct allegations shadow likely CDC appointee
March 21, 2018 - Most Breast Ca Patients Fail to Get Genetic Counseling
March 21, 2018 - Lopsided ear function can lead to lopsided brain development
March 21, 2018 - Acupuncture helps manage menopausal symptoms, review finds
March 21, 2018 - Motor skill training may contribute to reading skills in obese children
March 21, 2018 - Poor dental health may be related to increased diabetes risk
March 21, 2018 - Chronic opioid users at increased risk of complications after spinal fusion surgery
March 21, 2018 - Study uncovers potential therapeutic target against large family of parasites
March 21, 2018 - NSAID use linked to increased risk of atrial fibrillation
March 21, 2018 - Scientists develop brain “stethoscope” that can detect silent seizures
March 21, 2018 - New method predicts effects of global warming on disease
March 21, 2018 - Insurance Company Hurdles Burden Doctors, May Harm Patients
March 21, 2018 - Renal Transplant from HCV-Positive Donors Feasible
March 21, 2018 - Myelodysplastic syndrome: MedlinePlus Medical Encyclopedia
March 21, 2018 - Research reveals brain mechanism involved in language learning
March 21, 2018 - Many parents still hesitate to try early peanut introduction, survey finds
March 21, 2018 - Audiologist urges tinnitus sufferers facing ‘revolving door healthcare’ to seek support
March 21, 2018 - Study reveals impact of prostate cancer on wives and partners of sufferers
March 21, 2018 - ‘Almost a Miracle Drug’: What We Heard This Week
March 21, 2018 - Study shows NIH spent >$100 billion on basic science for new medicines
March 21, 2018 - Columbia researchers identify nerve cells that drive fruit fly’s escape behavior
March 21, 2018 - Sartorius Stedim Biotech selected by ABL Europe to supply single-use process technologies
March 21, 2018 - Increase in coffee consumption may help battle against colon cancer
March 21, 2018 - Hydrogel may accelerate healing of diabetic ulcers
March 21, 2018 - Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
March 21, 2018 - DePuy Synthes introduces ACTIS Total Hip System for improving initial implant stability
March 21, 2018 - ‘Oh, It Was Nothing’
March 21, 2018 - Herbal drug kratom linked to salmonella illnesses, CDC says
March 21, 2018 - New optical point-of-care device could enhance screening for thyroid nodules
March 21, 2018 - FDA Expands Approval of Adcetris (brentuximab vedotin) for First-Line Treatment of Stage III or IV Classical Hodgkin Lymphoma in Combination with Chemotherapy
March 21, 2018 - Eosinophilic Esophagitis: Late Manifestation of Allergic March
March 21, 2018 - Signaling pathway involving the Golgi apparatus identified in cells with Huntington’s disease
March 21, 2018 - Quintupling inhaled steroid doses may not benefit children with asthma
March 21, 2018 - Study shows clear connection between cardiovascular fitness in middle age and dementia risk
March 21, 2018 - Premature babies have higher risks of health complications in Bangladesh
March 21, 2018 - Child’s temperament and parenting influence weight gain in babies
March 21, 2018 - Researchers find the heart to be capable of arrhythmia termination after local gene therapy
March 21, 2018 - Inhealthcare to provide digital infrastructure for NHS to help protect people from falls
March 21, 2018 - Flu Season Finally Slowing Down
March 21, 2018 - Mixed Results for Shorter DAPT in ACS Patients
March 21, 2018 - Scientists discover fish scale-derived collagen effective for healing wounds
March 21, 2018 - Genomics England announces new partnership to improve efficiency of next-generation sequencing analysis
March 21, 2018 - Adjuvant AC chemotherapy found to be effective in treating HRD-positive breast cancer patients
March 21, 2018 - Researchers identify new treatment targets for lung diseases using big data
March 21, 2018 - Kids see more women in science than five decades ago
March 21, 2018 - Research shows link between chronic fatigue syndrome and lower thyroid hormone levels
March 21, 2018 - Alzheimer’s disease on the rise
March 21, 2018 - Two Agents Equal as Pretreatment for Adrenal Tumor Surgery
March 21, 2018 - ‘Icebreaker’ protein opens genome for T cell development, researchers find
March 21, 2018 - Women in medicine shout #Metoo about sexual harassment at work
March 21, 2018 - Mother’s pre-pregnancy waist size may be linked to child’s autism risk
March 21, 2018 - Second hand marijuana smoke can cause serious damage
March 21, 2018 - International study shows benefits of using MRI at the start of prostate cancer diagnosis
March 20, 2018 - Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
No Difference in Infant Cognitive Scores for Brain Injury Tx

No Difference in Infant Cognitive Scores for Brain Injury Tx

image_pdfDownload PDFimage_print

Action Points

  • Note that this small trial found similar overall results between VP-shunting and endoscopic treatment in children with post-infectious hydrocephalus.
  • The endoscopic procedure is more definitive, with a lower failure rate over time, but concerns of worse neurologic outcomes have limited its adoption up to this point.

There was no difference in cognitive outcomes when African infants with post-infectious hydrocephalus, an accumulation of cerebrospinal fluid in the brain, were treated with a shunt or a two-part procedure designed to divert the flow of fluid and cauterize certain areas of the brain, a small randomized trial found.

Infants who underwent endoscopic third ventriculostomy with choroid plexus cauterization (ETV-CPC) showed no difference in median cognitive scores at 12 months compared to infants treated with ventriculoperitoneal shunting, reported Abhaya V. Kulkarni, MD, of the University of Toronto Hospital for Sick Children, and colleagues.

There was also no difference in language or motor skills or in brain volume between the two procedures as performed in Uganda, the authors wrote in the New England Journal of Medicine.

They said that there is “uncertainty” regarding the benefits of the two procedures for infants with this condition. While shunting is technically straightforward, with a lower rate of failure in the months after surgery, the authors said, it has a higher long-term failure rate that often requires urgent surgery. In addition, “shunt failure can be fatal in regions of the world where there is no access to immediate neurological care,” they wrote.

But shunting is also thought to reduce the ventricle size more than ETV-CPC, which could lead to a better cognitive outcome for the patient, though the authors added that “this difference between procedures has been shown inconsistently.”

“Others have suggested that shunts are a better treatment in regard to neurologic development or brain growth, but we found this was not the case,” co-author Benjamin Warf, MD, of Boston Children’s Hospital said in a statement. “There are many advantages to avoiding lifelong dependence on a shunt.”

Researchers randomized 100 Ugandan infants with post-infectious hydrocephalus, who were less than 180 days of age, with a mother who was over 18, and lived in an area where they could complete follow-up. They were evaluated via the cognitive scaled score on the Bayley Scales of Infant Development, Third Edition, 12 months following surgery.

Overall, 42 infants underwent endoscopic ventriculostomy and 48 underwent placement of a ventriculoperitoneal-shunt. Infants were a mean age of about 3 months, and there were around 40% girls in both groups. Head circumference and cerebrospinal fluid volume was greater in the shunt group, the author said, but noted no other significant between-group differences at baseline.

There was no significant difference in median cognitive scores between the two groups at 12 months (4 in ETV-CPC group versus 2 in shunt group, 95% CI -2 to 0, P=0.35). Kulkarni and colleagues also found no significant difference in expressive language score, receptive language score, general motor score or fine motor score.

While there was no difference in brain volume at 12 months between groups, median cerebrospinal fluid volume was significantly lower in the shunt group than in the ETV-CPC group.

There were 18 treatment failures in the ETV-CPC group compared to 12 in the shunt group, but the difference was non-significant. In a statement, Warf characterized that finding as surprising.

“ETV/CPC is expected to have a higher short term failure rate, whereas shunts tend to fail more over time,” Warf said. “We expect that there will be no further ETV/CPC failures, which nearly all occur within 6 months, but that the shunts will continue to fail as we follow this cohort.”

There were nine deaths, two of which were treatment-related. One patient in the ETV-CPC group had treatment failure 8 months after surgery, the authors said, and one patient started in the ETV-CPC group, crossed over to shunting and developed ventriculitis (inflammation of the ventricles) and subdural empyema (a collection of pus in certain brain matter).

But they noted that “the overall developmental outcome was relatively poor for both treatments,” with nearly all patients starting with abnormally low brain volume at baseline, and only a quarter having normal brain volume by year 1, they said.

Limitations to the data include that it only addressed postinfectious hydrocephalus, that the single center nature of the trial limits generalizability, and a relatively short follow-up period of 1 year.

“We will continue to follow these children, but the results further raise our level of confidence in recommending ETV/CPC as the initial treatment for most infants with hydrocephalus,” Warf said.

This study was supported by the NIH, the National Institute of Child and Human Development, and the Fogarty International Center.

Kulkarni disclosed no conflicts of interest.

One co-author disclosed support from General Electric Global Research.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner


Tagged with:

About author

Related Articles